Literature DB >> 16511500

Evaluation of reference tissue models for the analysis of [11C](R)-PK11195 studies.

Marc A Kropholler1, Ronald Boellaard, Alie Schuitemaker, Hedy Folkersma, Bart N M van Berckel, Adriaan A Lammertsma.   

Abstract

[(11)C](R)-PK11195 is a marker of activated microglia, which can be used to measure inflammation in neurologic disorders. The purpose of the present study was to define the optimal reference tissue model based on a comparison with a validated plasma input model and using clinical studies and Monte Carlo simulations. Accuracy and reproducibility of reference tissue models were evaluated using Monte Carlo simulations. The effects of noise and variation in specific binding, nonspecific binding and blood volume were evaluated. Dynamic positron emission tomography scans were performed on 13 subjects, and radioactivity in arterial blood was monitored online. In addition, blood samples were taken to generate a metabolite corrected plasma input function. Both a (validated) two-tissue reversible compartment model with K(1)/k(2) fixed to whole cortex and various reference tissue models were fitted to the data. Finally, a simplified reference tissue model (SRTM) corrected for nonspecific binding using plasma input data (SRTM(pl_corr)) was investigated. Correlations between reference tissue models (including SRTM(pl_corr)) and the plasma input model were calculated. Monte Carlo simulations indicated that low-specific binding results in decreased accuracy and reproducibility. In this respect, the SRTM and SRTM(pl_corr) performed relatively well. Varying blood volume had no effect on performance. In the clinical evaluation, SRTM(pl_corr) and SRTM had the highest correlations with the plasma input model (R(2)=0.82 and 0.78, respectively). SRTM(pl_corr) is optimal when an arterial plasma input curve is available. Simplified reference tissue model is the best alternative when no plasma input is available.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511500     DOI: 10.1038/sj.jcbfm.9600289

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  24 in total

1.  Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.

Authors:  Yun Zhou; Susan M Resnick; Weiguo Ye; Hong Fan; Daniel P Holt; William E Klunk; Chester A Mathis; Robert Dannals; Dean F Wong
Journal:  Neuroimage       Date:  2007-03-16       Impact factor: 6.556

Review 2.  Molecular imaging of microglia/macrophages in the brain.

Authors:  Sriram Venneti; Brian J Lopresti; Clayton A Wiley
Journal:  Glia       Date:  2012-05-21       Impact factor: 7.452

3.  Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study.

Authors:  Akihiro Takano; Balázs Gulyás; Andrea Varrone; Per Karlsson; Nils Sjoholm; Stig Larsson; Cathrine Jonsson; Richard Odh; Richard Sparks; Nabil Al Tawil; Anja Hoffmann; Torsten Zimmermann; Andrea Thiele; Christer Halldin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-06       Impact factor: 9.236

4.  11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain.

Authors:  Masamichi Ikawa; Talakad G Lohith; Stal Shrestha; Sanjay Telu; Sami S Zoghbi; Sabrina Castellano; Sabrina Taliani; Federico Da Settimo; Masahiro Fujita; Victor W Pike; Robert B Innis
Journal:  J Nucl Med       Date:  2016-11-17       Impact factor: 10.057

5.  TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.

Authors:  Marcus Unterrainer; C Mahler; L Vomacka; S Lindner; J Havla; M Brendel; G Böning; B Ertl-Wagner; T Kümpfel; V M Milenkovic; R Rupprecht; M Kerschensteiner; P Bartenstein; Nathalie L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-09       Impact factor: 9.236

6.  Kinetic models for analysing myocardial [(11)C]palmitate data.

Authors:  Hugo W A M de Jong; Luuk J Rijzewijk; Mark Lubberink; Rutger W van der Meer; Hildo J Lamb; Jan W A Smit; Michaëla Diamant; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-27       Impact factor: 9.236

Review 7.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.

Authors:  Fabien Chauveau; Hervé Boutin; Nadja Van Camp; Frédéric Dollé; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

8.  Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis.

Authors:  M A Kropholler; R Boellaard; E H Elzinga; C J van der Laken; K Maruyama; R W Kloet; A E Voskuyl; B A C Dijkmans; A A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-29       Impact factor: 9.236

9.  Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

Authors:  Christopher J Endres; Martin G Pomper; Michelle James; Ovsev Uzuner; Dima A Hammoud; Crystal C Watkins; Aaron Reynolds; John Hilton; Robert F Dannals; Michael Kassiou
Journal:  J Nucl Med       Date:  2009-07-17       Impact factor: 10.057

10.  Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation.

Authors:  Masahiro Fujita; Masao Imaizumi; Sami S Zoghbi; Yota Fujimura; Amanda G Farris; Tetsuya Suhara; Jinsoo Hong; Victor W Pike; Robert B Innis
Journal:  Neuroimage       Date:  2007-11-22       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.